Compared to the general population, patients starting dialysis have an increased risk of death that is not attributable to a higher rate of death from cardiovascular causes, as previously thought, according to a study.

Children who have had an episode of diabetic ketoacidosis, a common complication of diabetes, may have persistent memory problems, according to a new study.

The ability of thiazolidinediones such as rosiglitazone to lower blood sugar levels in Type 2 diabetes is an indisputable benefit. But, the benefit has been tempered by the inconsistent evidence regarding the use of thiazolidinediones and the risk of cancer.

A 2-year update of a trial comparing liraglutide with a sulfonylurea in patients with Type 2 diabetes demonstrates that liraglutide continues to control hyperglycemia better than a sulfonylurea without increasing the risk for hypoglycemia.

A new U.K. study showed that eating white and oily fish regularly may provide protection against Type 2 diabetes but eating shellfish may have the opposite effect.

A large-scale trial in diabetes patients has provided new evidence on how best to add insulin to standard drugs to control blood sugar levels as Type 2 diabetes progresses.

Although evidence for intensive glucose lowering in Type 2 diabetes to prevent CVD is mixed, glucose lowering is still important for other reasons, debaters agreed at the International Diabetes Federation (IDF) 2009 World Diabetes Congress.

A history of foot ulcers is a significant predictor of mortality in diabetes patients, independent from comorbidities such as cardiovascular disease and nephropathy, according to study findings.

Research presented at the 20th World Diabetes Congress in Montreal provides further evidence that healthy behaviors reduce mortality in people with and without diabetes.

At least three new prescription diet drugs are in the final stages of development as pharmaceutical companies race to see which one will have the next big diet medication to hit the market.